News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
607,743 Results
Type
Article (60117)
Company Profile (119)
Press Release (547504)
Multimedia
Podcasts (72)
Webinars (18)
Section
Business (160749)
Career Advice (1455)
Deals (25591)
Drug Delivery (100)
Drug Development (67451)
Employer Resources (104)
FDA (14582)
Job Trends (12794)
News (273702)
Policy (26061)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (3)
Academia (2887)
Academic (1)
Accelerated approval (48)
ADA (37)
Adcomms (22)
Allergies (192)
Alliances (44053)
ALS (194)
Alzheimer's disease (1729)
Antibody-drug conjugate (ADC) (440)
Approvals (15073)
Artificial intelligence (684)
ASCO (271)
Autoimmune disease (311)
Automation (40)
Bankruptcy (201)
Best Places to Work (9770)
BIO (54)
BIOSECURE Act (11)
Biosimilars (154)
Biotechnology (79)
Bladder cancer (184)
Brain cancer (72)
Breast cancer (717)
Cancer (5657)
Cardiovascular disease (424)
Career advice (1245)
Career pathing (38)
CAR-T (294)
CDC (47)
Celiac Disease (3)
Cell therapy (794)
Cervical cancer (51)
Clinical research (58952)
Collaboration (2049)
Commercialization (1)
Company closure (2)
Compensation (518)
Complete response letters (67)
COVID-19 (2580)
CRISPR (102)
C-suite (1053)
Cystic fibrosis (134)
Data (7854)
Decentralized trials (3)
Denatured (30)
Depression (169)
Dermatology (84)
Diabetes (560)
Diagnostics (5911)
Digital health (58)
Diversity (10)
Diversity, equity & inclusion (27)
Drug discovery (337)
Drug pricing (153)
Drug shortages (26)
Duchenne muscular dystrophy (260)
Earnings (63499)
Editorial (62)
Employer branding (16)
Employer resources (96)
Events (83546)
Executive appointments (976)
FDA (18266)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (17)
Frontotemporal dementia (27)
Funding (1588)
Gene editing (197)
Generative AI (52)
Gene therapy (616)
GLP-1 (894)
Government (4220)
Grass and pollen (8)
Guidances (391)
Healthcare (16675)
Hematology (162)
HIV (75)
Huntington's disease (45)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (84)
Immunology and inflammation (183)
Immuno-oncology (87)
Indications (199)
Infectious disease (2885)
Inflammatory bowel disease (191)
Inflation Reduction Act (8)
Influenza (123)
Intellectual property (262)
Interviews (279)
IPO (11319)
IRA (40)
Job creations (3296)
Job search strategy (1056)
JPM (35)
Kidney cancer (18)
Labor market (85)
Layoffs (412)
Leadership (23)
Legal (5143)
Liver cancer (92)
Longevity (28)
Lung cancer (761)
Lymphoma (431)
Machine learning (56)
Management (35)
Manufacturing (836)
Marketing (4)
MASH (187)
Medical affairs (1)
Medical device (14299)
Medtech (14474)
Mergers & acquisitions (15308)
Metabolic disorders (1321)
mRNA (192)
Multiple sclerosis (172)
NASH (13)
Neurodegenerative disease (394)
Neuropsychiatric disorders (84)
Neuroscience (3180)
Neurotech (1)
NextGen: Class of 2026 (5451)
Non-profit (4378)
Now hiring (70)
Obesity (533)
Opinion (247)
Ovarian cancer (227)
Pain (236)
Pancreatic cancer (309)
Parkinson's disease (377)
Partnered (32)
Patents (505)
Patient recruitment (716)
Peanut (67)
People (50627)
Pharmaceutical (24)
Pharmacy benefit managers (19)
Phase 1 (18070)
Phase 2 (25627)
Phase 3 (19753)
Pipeline (8979)
Policy (268)
Postmarket research (2381)
Preclinical (8262)
Press Release (66)
Prostate cancer (312)
Psychedelics (48)
Radiopharmaceuticals (315)
Rare diseases (959)
Real estate (5302)
Recruiting (40)
Regulatory (21802)
Reports (35)
Research institute (2682)
Resumes & cover letters (209)
Rett syndrome (37)
RNA editing (16)
RSV (74)
Schizophrenia (180)
Series A (248)
Series B (168)
Service/supplier (9)
Sickle cell disease (101)
Special edition (23)
Spinal muscular atrophy (155)
Sponsored (37)
Startups (3188)
Stomach cancer (13)
Supply chain (101)
Tariffs (52)
The Weekly (42)
Vaccines (1005)
Venture capital (76)
Weight loss (338)
Women's health (112)
Worklife (12)
Date
Today (104)
Last 7 days (340)
Last 30 days (1740)
Last 365 days (24286)
2026 (13189)
2025 (24397)
2024 (28929)
2023 (33353)
2022 (44033)
2021 (47427)
2020 (45851)
2019 (39927)
2018 (30273)
2017 (27682)
2016 (27245)
2015 (32220)
2014 (25099)
2013 (22240)
2012 (22899)
2011 (23488)
2010 (21986)
Location
Africa (723)
Alabama (88)
Alaska (5)
Arizona (287)
Arkansas (12)
Asia (37418)
Australia (6558)
California (10548)
Canada (3179)
China (1382)
Colorado (514)
Connecticut (520)
Delaware (372)
Europe (88418)
Florida (1766)
Georgia (402)
Hawaii (2)
Idaho (47)
Illinois (1002)
India (85)
Indiana (574)
Iowa (21)
Japan (573)
Kansas (122)
Kentucky (39)
Louisiana (53)
Maine (38)
Maryland (1427)
Massachusetts (7493)
Michigan (328)
Minnesota (640)
Mississippi (7)
Missouri (118)
Montana (34)
Nebraska (27)
Nevada (112)
New Hampshire (88)
New Jersey (3186)
New Mexico (30)
New York (3071)
North Carolina (1566)
North Dakota (10)
Northern California (5220)
Ohio (377)
Oklahoma (16)
Oregon (33)
Pennsylvania (2220)
Puerto Rico (23)
Rhode Island (52)
South America (904)
South Carolina (87)
Southern California (4300)
Tennessee (208)
Texas (1846)
United States (39562)
Utah (333)
Vermont (1)
Virginia (306)
Washington D.C. (73)
Washington State (923)
West Virginia (4)
Wisconsin (125)
Wyoming (1)
607,743 Results for "uk medical research council mrc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TrialAssure and Cancer Research UK Collaborate to Advance AI-Supported Regulatory Document Authoring
Cancer Research UK’s Centre for Drug Development is using TrialAssure LINK AI to support medical writing in CRUK-sponsored studies
June 18, 2026
·
1 min read
Press Releases
Stealth BioTherapeutics Announces MRC Business Engagement Fund Grant to Advance Mitochondrial Disease Research
March 23, 2026
·
4 min read
Press Releases
Zelluna ASA awarded NOK 16 million Research Council of Norway grant
June 30, 2026
·
1 min read
Insights
The Golden Triangle and the gaps: Rethinking UK biotech
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you’ll hear from Hakan Goker, managing director at M Ventures and Maina Bhaman, partner at Sofinnova Partners. We explore the UK biotech ecosystem: from the Golden Triangle’s evolving role to the challenges of scaling companies, unlocking pension capital and staying globally competitive.
June 25, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Velocity Clinical Research Appoints UK Medical Director
February 12, 2026
·
4 min read
Press Releases
Council of Chief Medical Officers of Health (CCMOH) Statement to Canadians on Vaccination
April 27, 2026
·
3 min read
Press Releases
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
June 15, 2026
·
5 min read
Press Releases
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
June 18, 2026
·
7 min read
Huntington’s disease
UniQure eyes UK approval for embattled Huntington’s gene therapy after FDA quarrel
UniQure plans to submit AMT-130 to the U.K.’s Medicines and Healthcare products Regulatory Agency in the third quarter of 2026 based on Phase 1/2 data showing a 75% slowing of disease—the same data the FDA has deemed unacceptable for a biologics license application.
April 30, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter
April 20, 2026
·
4 min read
1 of 60,775
Next
